MolSoft groupGen and LigandAIDE review
Pocket-conditioned R-group design and iterative ligand growth for structure-based workflows.
Reviewed by iTechGuides Editors · Editorial team · Updated Oct 2026
MolSoft groupGen and Ligand AIDE are structure-based generative design workflows for drug-discovery teams working with protein–ligand structures. They focus on molecule design rather than target identification or drug repurposing. groupGen proposes R-group substitutions at a selected ligand attachment point, while Ligand AIDE grows and optimizes ligands from docked fragments. This makes the pair most relevant to teams with a known binding pocket and a structure-guided design workflow, rather than groups looking for a broader discovery platform.
The central distinction is how pocket context shapes generation and selection. groupGen uses binding-pocket geometry along with electrostatic and hydrophobic descriptors to guide substitutions, and uses an Atom Predictor for atom-level changes. Ligand AIDE supports iterative de novo growth from docked fragments, followed by redocking generated ligand cohorts into the binding site. Designs can then be selected using binding scores and drug-like property filters; generated analogs are also scored for synthesizability, with strain reported. These linked steps suit teams that want to generate and assess ligand analogs in the context of a protein structure, though they do not replace work that begins with target discovery.
Both workflows are described as part of MolSoft’s ICM desktop modeling environment, with Windows, macOS, Linux, and self-hosted options listed. The vendor describes cloud availability for ICM screening and modeling workloads, but that does not establish groupGen or Ligand AIDE as hosted SaaS. According to the vendor’s pricing information, ICM licensing is available annually, for multiple years, or perpetually, with pricing handled through sales; groupGen also requires an additional license key. Teams should consider this combination if they have structural inputs and want pocket-conditioned ligand growth. Those seeking published prices, a workflow centered on target identification, or confirmed hosted access specifically for these tools should consider alternatives.
MolSoft groupGen and LigandAIDE pros and cons
- Where it wins
- Guides R-group substitutions with pocket geometry and chemical descriptors
- Grows ligands iteratively from docked fragments, then redocks cohorts
- Filters designs by binding scores, drug-like properties, and synthesizability
- Where it doesn't
- Requires protein–ligand structures and a defined binding site
- groupGen requires an additional license key
- Pricing is handled through sales rather than published plan prices
MolSoft groupGen and LigandAIDE fact sheet, pricing and score →
Advertiser disclosure: iTechGuides is reader-supported. Vendors can pay for top positions in our rankings and for a place on other products' pages, and we may earn a commission when you click some links. Bought places stand at the number bought; this page and our disclosure say so. Paying vendors may get a fuller, more detailed review from our editors, and that review can change their score. How we rank.
Last updated · How we research and update